🇺🇸 FDA
Patent

US 9120744

Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

granted A61KA61K31/166A61K31/18

Quick answer

US patent 9120744 (Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/166, A61K31/18, A61K31/235, A61K31/27